In Vivo Models
Menu
Providing end-to-end services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions accelerate research and innovation.
InVivo Biosystems And Thaena Announce Novel Metabolite Research Platform With Compelling Longevity And Healthspan Implications And Outcomes.
Read the Press Release. >>
Year Established
Number of Employees
Number of PhDs
Average Years of Experience in Genetics
Number of Preclinical Models Created
Publications
Bridge the data gap between cell culture and rodent models. Rapidly conduct preclinical studies to de-risk your clinical trial.
An expert in CRISPR genome editing for creating custom genome edited zebrafish and C. elegans, our CRISPR genome editing platform enables preclinical studies and drug discovery by providing insights you need to derisk your clinical trial or decide the next phase of product devleopment.
Vitality & Antioxidant Study Report – an example of a client project report.
Download our sample data report to see an example of the dataset you would receive if you partnered with us.
Our newest white paper focus on the gut microbiome and discusses the questions: What is the microbiome? How does it help or hinder health? And, what does recent research indicate?
Dr. Marius Galyan (CEO and Founder at Galyan Bio, Inc.) shares his experience in working with InVivo Biosystems and how the Longevity Platform delivered the results he needed to accelerate his research.
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.
